Cite
Garcia CA, Bhargav AG, Brooks M, et al. Functional Characterization of Brain Tumor-Initiating Cells and Establishment of GBM Preclinical Models that Incorporate Heterogeneity, Therapy, and Sex Differences. Mol Cancer Ther. 2021;20(12):2585-2597doi: 10.1158/1535-7163.MCT-20-0547.
Garcia, C. A., Bhargav, A. G., Brooks, M., Suárez-Meade, P., Mondal, S. K., Zarco, N., ReFaey, K., Jentoft, M., Middlebrooks, E. H., Snuderl, M., Carrano, A., Guerrero-Cazares, H., Schiapparelli, P., Sarabia-Estrada, R., & Quiñones-Hinojosa, A. (2021). Functional Characterization of Brain Tumor-Initiating Cells and Establishment of GBM Preclinical Models that Incorporate Heterogeneity, Therapy, and Sex Differences. Molecular cancer therapeutics, 20(12), 2585-2597. https://doi.org/10.1158/1535-7163.MCT-20-0547
Garcia, Cesar A, et al. "Functional Characterization of Brain Tumor-Initiating Cells and Establishment of GBM Preclinical Models that Incorporate Heterogeneity, Therapy, and Sex Differences." Molecular cancer therapeutics vol. 20,12 (2021): 2585-2597. doi: https://doi.org/10.1158/1535-7163.MCT-20-0547
Garcia CA, Bhargav AG, Brooks M, Suárez-Meade P, Mondal SK, Zarco N, ReFaey K, Jentoft M, Middlebrooks EH, Snuderl M, Carrano A, Guerrero-Cazares H, Schiapparelli P, Sarabia-Estrada R, Quiñones-Hinojosa A. Functional Characterization of Brain Tumor-Initiating Cells and Establishment of GBM Preclinical Models that Incorporate Heterogeneity, Therapy, and Sex Differences. Mol Cancer Ther. 2021 Dec;20(12):2585-2597. doi: 10.1158/1535-7163.MCT-20-0547. Epub 2021 Aug 31. PMID: 34465594; PMCID: PMC8687628.
Copy
Download .nbib